Report Detail
Global Hepatocyte Growth Factor Market Growth 2019-2024
- RnM2847859 |
- 31 January, 2019 |
- Global |
- 131 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Hepatocyte growth factor (HGF) (or scatter factor (SF) is a paracrine cellular growth, motility and morphogenic factor. It is secreted by mesenchymal cells and targets and acts primarily upon epithelial cells and endothelial cells, but also acts on haemopoietic progenitor cells and T cells. It has been shown to have a major role in embryonic organ development, specifically in myogenesis, in adult organ regeneration, and in wound healing.
The application of hepatocyte growth factor includes oncology, cardiovascular, central nervous system, hematological disorders and others, and the proportion of R&D Investment for oncology in 2017 is about 36%, and the proportion is in decreasing trend from 2012 to 2016.
Asia Pacific will be the largest market, which will occupy nearly 62% market share in 2030. Following Asia Pacific, North America will be the second largest market with the consumption market share of 25% in 2030.
According to this study, over the next five years the Hepatocyte Growth Factor market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Hepatocyte Growth Factor business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Hepatocyte Growth Factor market by product type, application, key manufacturers and key regions and countries.
This study considers the Hepatocyte Growth Factor value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Type I
Type II
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Oncology
Cardiovascular
Central Nervous System
Hematological Disorders
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
ViroMed
AnGes MG
M3 Biotechnology
AVEO Pharmaceuticals
Molecular Partners
Yooyoung Pharm
F-star
Galaxy Biotech
Kringle Pharma
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Hepatocyte Growth Factor consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Hepatocyte Growth Factor market by identifying its various subsegments.
Focuses on the key global Hepatocyte Growth Factor manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Hepatocyte Growth Factor with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Hepatocyte Growth Factor submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Hepatocyte Growth Factor Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Hepatocyte Growth Factor Consumption 2014-2024
- 2.1.2 Hepatocyte Growth Factor Consumption CAGR by Region
- 2.2 Hepatocyte Growth Factor Segment by Type
- 2.2.1 Type I
- 2.2.2 Type II
- 2.3 Hepatocyte Growth Factor Consumption by Type
- 2.3.1 Global Hepatocyte Growth Factor Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Hepatocyte Growth Factor Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Hepatocyte Growth Factor Sale Price by Type (2014-2019)
- 2.4 Hepatocyte Growth Factor Segment by Application
- 2.4.1 Oncology
- 2.4.2 Cardiovascular
- 2.4.3 Central Nervous System
- 2.4.4 Hematological Disorders
- 2.4.5 Others
- 2.5 Hepatocyte Growth Factor Consumption by Application
- 2.5.1 Global Hepatocyte Growth Factor Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Hepatocyte Growth Factor Value and Market Share by Application (2014-2019)
- 2.5.3 Global Hepatocyte Growth Factor Sale Price by Application (2014-2019)
3 Global Hepatocyte Growth Factor by Players
- 3.1 Global Hepatocyte Growth Factor Sales Market Share by Players
- 3.1.1 Global Hepatocyte Growth Factor Sales by Players (2017-2019)
- 3.1.2 Global Hepatocyte Growth Factor Sales Market Share by Players (2017-2019)
- 3.2 Global Hepatocyte Growth Factor Revenue Market Share by Players
- 3.2.1 Global Hepatocyte Growth Factor Revenue by Players (2017-2019)
- 3.2.2 Global Hepatocyte Growth Factor Revenue Market Share by Players (2017-2019)
- 3.3 Global Hepatocyte Growth Factor Sale Price by Players
- 3.4 Global Hepatocyte Growth Factor Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Hepatocyte Growth Factor Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Hepatocyte Growth Factor Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Hepatocyte Growth Factor by Regions
- 4.1 Hepatocyte Growth Factor by Regions
- 4.1.1 Global Hepatocyte Growth Factor Consumption by Regions
- 4.1.2 Global Hepatocyte Growth Factor Value by Regions
- 4.2 Americas Hepatocyte Growth Factor Consumption Growth
- 4.3 APAC Hepatocyte Growth Factor Consumption Growth
- 4.4 Europe Hepatocyte Growth Factor Consumption Growth
- 4.5 Middle East & Africa Hepatocyte Growth Factor Consumption Growth
5 Americas
- 5.1 Americas Hepatocyte Growth Factor Consumption by Countries
- 5.1.1 Americas Hepatocyte Growth Factor Consumption by Countries (2014-2019)
- 5.1.2 Americas Hepatocyte Growth Factor Value by Countries (2014-2019)
- 5.2 Americas Hepatocyte Growth Factor Consumption by Type
- 5.3 Americas Hepatocyte Growth Factor Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Hepatocyte Growth Factor Consumption by Countries
- 6.1.1 APAC Hepatocyte Growth Factor Consumption by Countries (2014-2019)
- 6.1.2 APAC Hepatocyte Growth Factor Value by Countries (2014-2019)
- 6.2 APAC Hepatocyte Growth Factor Consumption by Type
- 6.3 APAC Hepatocyte Growth Factor Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Hepatocyte Growth Factor by Countries
- 7.1.1 Europe Hepatocyte Growth Factor Consumption by Countries (2014-2019)
- 7.1.2 Europe Hepatocyte Growth Factor Value by Countries (2014-2019)
- 7.2 Europe Hepatocyte Growth Factor Consumption by Type
- 7.3 Europe Hepatocyte Growth Factor Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Hepatocyte Growth Factor by Countries
- 8.1.1 Middle East & Africa Hepatocyte Growth Factor Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Hepatocyte Growth Factor Value by Countries (2014-2019)
- 8.2 Middle East & Africa Hepatocyte Growth Factor Consumption by Type
- 8.3 Middle East & Africa Hepatocyte Growth Factor Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Hepatocyte Growth Factor Distributors
- 10.3 Hepatocyte Growth Factor Customer
11 Global Hepatocyte Growth Factor Market Forecast
- 11.1 Global Hepatocyte Growth Factor Consumption Forecast (2019-2024)
- 11.2 Global Hepatocyte Growth Factor Forecast by Regions
- 11.2.1 Global Hepatocyte Growth Factor Forecast by Regions (2019-2024)
- 11.2.2 Global Hepatocyte Growth Factor Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Hepatocyte Growth Factor Forecast by Type
- 11.8 Global Hepatocyte Growth Factor Forecast by Application
12 Key Players Analysis
- 12.1 ViroMed
- 12.1.1 Company Details
- 12.1.2 Hepatocyte Growth Factor Product Offered
- 12.1.3 ViroMed Hepatocyte Growth Factor Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 ViroMed News
- 12.2 AnGes MG
- 12.2.1 Company Details
- 12.2.2 Hepatocyte Growth Factor Product Offered
- 12.2.3 AnGes MG Hepatocyte Growth Factor Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 AnGes MG News
- 12.3 M3 Biotechnology
- 12.3.1 Company Details
- 12.3.2 Hepatocyte Growth Factor Product Offered
- 12.3.3 M3 Biotechnology Hepatocyte Growth Factor Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 M3 Biotechnology News
- 12.4 AVEO Pharmaceuticals
- 12.4.1 Company Details
- 12.4.2 Hepatocyte Growth Factor Product Offered
- 12.4.3 AVEO Pharmaceuticals Hepatocyte Growth Factor Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 AVEO Pharmaceuticals News
- 12.5 Molecular Partners
- 12.5.1 Company Details
- 12.5.2 Hepatocyte Growth Factor Product Offered
- 12.5.3 Molecular Partners Hepatocyte Growth Factor Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Molecular Partners News
- 12.6 Yooyoung Pharm
- 12.6.1 Company Details
- 12.6.2 Hepatocyte Growth Factor Product Offered
- 12.6.3 Yooyoung Pharm Hepatocyte Growth Factor Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Yooyoung Pharm News
- 12.7 F-star
- 12.7.1 Company Details
- 12.7.2 Hepatocyte Growth Factor Product Offered
- 12.7.3 F-star Hepatocyte Growth Factor Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 F-star News
- 12.8 Galaxy Biotech
- 12.8.1 Company Details
- 12.8.2 Hepatocyte Growth Factor Product Offered
- 12.8.3 Galaxy Biotech Hepatocyte Growth Factor Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Galaxy Biotech News
- 12.9 Kringle Pharma
- 12.9.1 Company Details
- 12.9.2 Hepatocyte Growth Factor Product Offered
- 12.9.3 Kringle Pharma Hepatocyte Growth Factor Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Kringle Pharma News
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Hepatocyte Growth Factor . Industry analysis & Market Report on Hepatocyte Growth Factor is a syndicated market report, published as Global Hepatocyte Growth Factor Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Hepatocyte Growth Factor market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
